Acute myeloid leukemia with 11q23 abnormalities Advocacy Hub | UniteRare

At a Glance

Live from database

Regulatory Watchboard

10 events

Jul 2026Venetoclax or Placebo in Combination With Reduced-Intensity Conditioning Hematopoietic Cell (Bone Marrow/Blood Stem Cell) Transplant and as Maintenance Therapy After Transplant in Patients With Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)

National Cancer Institute (NCI) — PHASE2

TrialNOT YET RECRUITING

Feb 2026GRanulocyte Augmented Cord Blood Transplantation for Poor Risk leukaEmia

University of Manchester — PHASE1, PHASE2

TrialNOT YET RECRUITING

Oct 2025Evaluating the Effects of Hemoglobin Threshold-specific Packed Red Blood Cell Transfusions on Quality of Life and Functional Outcomes in Patients With High-grade Myeloid Neoplasms, Acute Myeloid Leukemia, or B Acute Lymphoblastic Lymphoma/Leukemia

University of Washington — NA

TrialRECRUITING

Sep 2025Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

Kura Oncology, Inc. — PHASE3

TrialRECRUITING

Sep 2025Chemotherapy (Decitabine in Combination With FLAG-Ida) and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Adults With Myeloid Malignancies at High Risk of Relapse

Fred Hutchinson Cancer Center — PHASE1, PHASE2

TrialRECRUITING

Jun 2025CD180 CART for Relapsed or Refractory CD180 Positive Hematologic Malignancies

Institute of Hematology & Blood Diseases Hospital, China — PHASE1

TrialRECRUITING

Mar 2025A Phase I Study Investigating the Combination of the Menin Inhibitor Ziftomenib With Venetoclax and Gemtuzumab in Pediatric Patients With Acute Myeloid Leukemia

M.D. Anderson Cancer Center — PHASE1

TrialRECRUITING

Feb 2025UCMSC-Exo for Chemotherapy-induced Myelosuppression in Acute Myeloid Leukemia

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology — PHASE1

TrialRECRUITING

Nov 2024Using Multiparametric Flow Cytometry to Detect Peripheral Blood and Bone Marrow Leukaemia Stem Cells for Relapse Prediction in P-AML

Peking University People's Hospital

TrialRECRUITING

Oct 2024The Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation in Newly Diagnosed High-relapse-risk CEBPA Mutant Acute Myeloid Leukemia

Ruijin Hospital

TrialRECRUITING

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

Total programs

No financial assistance programs currently listed for Acute myeloid leukemia with 11q23 abnormalities.
Check the disease page for updates →

Clinical Trial Landscape

36 active trials

5Phase 3

6Phase 2

10Phase 1

1N/A

6Unknown

8PHASE1, PHASE2

36Total recruiting

Search clinical trials for Acute myeloid leukemia with 11q23 abnormalities →

Recent News & Research

No recent news articles indexed yet for Acute myeloid leukemia with 11q23 abnormalities.
Search PubMed for Acute myeloid leukemia with 11q23 abnormalities →

Browse all Acute myeloid leukemia with 11q23 abnormalities news →

Specialist Network

Top 6 by expertise

Soheil Meshinchi, MD, MD,PhD

Fred Hutchinson Cancer Center

📍 SEATTLE, WA

Score 184 trials

B. Smith, M.S.W., L.C.S.W

Johns Hopkins University

📍 OKLAHOMA CITY, OK

Score 186 trials

Leona Holmberg

Fred Hutch/University of Washington Cancer Consortium

📍 SEATTLE, WA

Score 128 trials

Guido Marcucci, M.D

Ohio State University

📍 DUARTE, CA

Score 105 trials9 pubs

Bart Scott

Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium

📍 SEATTLE, WA

Score 103 trials

Thomas G. Martin, MD

University of California, San Francisco

Score 94 trials

View all Acute myeloid leukemia with 11q23 abnormalities specialists →

Quick Actions

📄

View Disease Page

Full profile, treatments, community

🔬

Search Clinical Trials

Find recruiting studies now

🩺

Find Specialists

Ranked by expertise & trials

💰

Financial Assistance

Copay cards, PAPs, grants

📰